| abstract |
FIELD: medicine. n SUBSTANCE: invention relates to a hypoxia-oriented anti-tumoral product containing, as an active ingredient, 3-bromopyruvate 1-isobutanoyl-2-isopropylisothiourea by the formula (I) in doses of 10 to 20 mg/kg, containing 0.1 to 2% of the active substance in solutions for injections or infusions and 1 to 50 mg of the active substance in solid dosage forms. n (I) n EFFECT: proposed is hypoxia-oriented product for treatment of tumours. n 1 cl, 3 tbl, 5 ex |